MindWalk Holdings, Inc. (HYFT): Kapitalizatsiyaning daromadga nisbati

MindWalk Therapeutics (HYFT) brendining ramzi va logotipi

GURU.Markets grafigidagi ma'lumotlar ketma-ketligidagi narx-savdo ko'rsatkichi tendentsiyasi rutiniy vazifalarni bartaraf etish uchun IT infratuzilmasini robotlashtirishning ta'sirini namoyish etadi va ushbu qiymat 3.90 deb qayd etilgan. MindWalk Holdings (HYFT) raqamli sog'liqni saqlash va tibbiy ma'lumotlar tahlili, shuningdek, Big Data yordamida immunologik dori vositalarini ishlab chiqishni tezlashtirish orqali daromad keltiradi, bu esa kompaniyaning joriy bozor qiymatini belgilaydi.

MindWalk Holdings, Inc. (HYFT): Narxning daromadga nisbati 05.09.2025dan 16.11.2026gacha

ipatherapeutics.com (HYFT) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning umumiy tahlili:HYFT MindWalk Holdings, Inc.
MindWalk Holdings tomonidan chiqariladigan mahsulotlar

MindWalk Holdings (HYFT) kompaniyasining xususiy sog'liqni saqlash sektoridagi AI ekotizimini rivojlantirishi yuqori B2B mijozlar sodiqligi hisobiga barqaror daromad oqimini ta'minlaydi. P/S ko'rsatkichi kompaniyaning umumiy bozor kapitalizatsiyasini uning savdo hajmi bilan bog'lab, hosil qilingan daromadning har bir birligi uchun sarflangan xarajatni o'lchaydi. Ushbu ko'rsatkichning pasayishi aktiv uchun haddan tashqari ko'p to'lash xavfini minimallashtiradi, garchi bu sanoatning raqamlashtirish sur'atlari sekinlashayotganidan dalolat berishi mumkin bo'lsa-da. P/S ko'rsatkichi tendentsiyasini tahlil qilish orqali investor aksiyalarning fundamental jozibadorligini biznesning operatsion muvaffaqiyatlariga nisbatan baholaydi.

MindWalk Holdings raqobatchilari

HLN (Haleon) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Kenvue Inc KVUE|Verona Pharma Corp - Narxning daromadga nisbati|MENS: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Ligand Pharmaceuticals LGND|Amneal Pharmaceuticals Inc (AMRX) - Narxning daromadga nisbati|Perrigo Company PLC - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati alvotech.com|P/S multiplikatori Liquidia Technologies|Narxning daromadga nisbati Galapagos Genomics (GLPG)|ANIP: Narxning sotuvga nisbati|P/S multiplikatori MNKD (MannKind Corp)|Narx/daromad koeffitsiyenti Amphastar (AMPH)|PCRX: Kapitalizatsiyaning daromadga nisbati|SPRY - P/S multiplikatori|Theravance Biopharma, Inc. (TBPH) - Narxning daromadga nisbati|AQST (Aquestive Therapeutics) - Narxning daromadga nisbati|SCPH (scpharmaceuticals.com) - P/S multiplikatori|TECX: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Tonix Pharmaceuticals Inc. (TNXP)|SXTC (SXT Pharmaceuticals) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori EPRX (Eupraxia Pharmaceuticals)|Bozor kapitallashuvining daromadga nisbati BHST|Invizyne Technologies - P/S multiplikatori|oramed.com (ORMP) - Kapitalizatsiyaning daromadga nisbati|ENTX (enterabio.com) - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati ABVC BioPharma Inc|CPIX (Cumberland Corp) - P/S multiplikatori|P/S multiplikatori quantumbiopharma.com|P/S multiplikatori FGEN|Kapitalizatsiyaning daromadga nisbati Telomir Pharmaceuticals, Inc. TELO|P/S multiplikatori RANI (Rani Therapeutics)|SNYR (Synergy CHC Corp) - Narxning sotuvga nisbati|RLYB: Kapitalizatsiyaning daromadga nisbati|lexariabioscience.com (LEXX) - Kapitalizatsiyaning daromadga nisbati|Pulmatrix Inc (PULM) - Narxning daromadga nisbati|PTHL: Kapitalizatsiyaning sotish hajmiga nisbati|APM (Aptorum Group Ltd) - P/S multiplikatori|Lyra Therapeutics Inc (LYRA) - Narx/daromad koeffitsiyenti|P/S multiplikatori IBO|Kapitalizatsiyaning sotish hajmiga nisbati TNFA|cbdMD, Inc. - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati PRFX|Altamira Therapeutics Ltd. - P/S multiplikatori|LIPO: Narxning daromadga nisbati|OPTN: P/S multiplikatori|Narxning sotuvga nisbati PIRS (Pieris Pharmaceuticals)|PROC (Procaps) - P/S multiplikatori|PTPI (Petros Pharmaceuticals Inc) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori QLI|SLRN - Sotuvga nisbatan narx|P/S multiplikatori TFFP (TFF Pharmaceuticals, Inc)